Details
Stereochemistry | RACEMIC |
Molecular Formula | C25H23ClN4O4 |
Molecular Weight | 478.928 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=NC2=NC(=CC=C2C=C1)N3C(CC(=O)N4CCC5(CC4)OCCO5)C6=CC=CC=C6C3=O
InChI
InChIKey=DPGKFACWOCLTCA-UHFFFAOYSA-N
InChI=1S/C25H23ClN4O4/c26-20-7-5-16-6-8-21(28-23(16)27-20)30-19(17-3-1-2-4-18(17)24(30)32)15-22(31)29-11-9-25(10-12-29)33-13-14-34-25/h1-8,19H,9-15H2
Molecular Formula | C25H23ClN4O4 |
Molecular Weight | 478.928 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Isoindoline pazinaclone (also known as DN-2327), a partial agonist at GABAA benzodiazepine receptors, produced anxiolytic, taming and anti-convulsive effects. This neuropsychiatric drug was involved in phase II clinical trial for patients with generalized anxiety disorder. However, this study was discontinued.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://adisinsight.springer.com/drugs/800000717
pazinaclone 8 mg/day bid for 4 weeks in a placebo-controlled study involving 126 patients
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:44:17 GMT 2023
by
admin
on
Fri Dec 15 18:44:17 GMT 2023
|
Record UNII |
MHK03047IJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID70869388
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107504
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
103255-66-9
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
C96874
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
MHK03047IJ
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
EE-67
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
C060382
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
100000083002
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
59743
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
PAZINACLONE
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
SUB09639MIG
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
7190
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | |||
|
m867
Created by
admin on Fri Dec 15 18:44:17 GMT 2023 , Edited by admin on Fri Dec 15 18:44:17 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->PARTIAL AGONIST |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
ENANTIOMER -> RACEMATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|